China Pharma Holdings
CPHI
6 hedge funds and large institutions have $322K invested in China Pharma Holdings in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
13% less capital invested
Capital invested by funds: $368K → $322K (-$46K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$9.31K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.78K |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$45.1K |
| 2 |
Renaissance Technologies
New York
|
-$5.78K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$482 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $246K | -$5.78K | -36 | -2% |
|
|
PAM
2
Panagora Asset Management
Boston,
Massachusetts
| $33K | -$482 | -3 | -1% |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $24K | -$45.1K | -281 | -65% |
|
|
VF
4
Virtu Financial
New York
| $9K | +$9.31K | +58 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $7K | +$5.78K | +36 | +600% |
|
|
PCM
6
Parsons Capital Management
Providence,
Rhode Island
| $3K | – | – | – |
|
CPHI Hedge Fund Activity: Q2 2019 in Review
6 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2019, worth a combined $322K — down 13% from $368K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CPHI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $9.31K. The largest seller was Deutsche Bank, cutting an estimated $45.1K.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q2 2019, up from 5 in Q1 2019.
- Funds reported $322K of China Pharma Holdings stock for Q2 2019, down 13% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q2 2019 and 0 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q2 2019 was Virtu Financial, an estimated $9.31K added.
- The largest China Pharma Holdings seller in Q2 2019 was Deutsche Bank, an estimated $45.1K sold.
Based on aggregated 13F filings for Q2 2019.